Eight firms express interest in developing monkeypox vaccine to ICMR

ICMR has received 31 bids from manufacturers showing interest in developing vaccine and diagnostic kits against the monkeypox virus after the medical body floated the Expression of Interest (EOI)

monkeypox
Illustration: Reuters
IANS New Delhi
2 min read Last Updated : Aug 14 2022 | 6:49 AM IST

The Indian Council of Medical Research (ICMR) has received 31 bids from manufacturers showing interest in developing vaccine against the monkeypox virus after the medical body floated the Expression of Interest (EOI) for the development of vaccine and diagnostic kits, a source said on Saturday.

According to the source, of the total 31 bids, eight companies have submitted the EOI for the vaccine development while 23 firms showed interest towards the development of kits.

However, no company has been awarded the tender yet and it is currently under evaluation, the source added. The manufacturers would develop the vaccine through public-private partnership.

The ICMR had invited the EOI for the development of vaccine and diagnostic kits for monkeypox last month on July 27.

The EOI was invited from the experienced vaccine manufacturers, in-vitro diagnostic (IVD) kit manufacturers for joint collaboration in developing of vaccine candidate against monkeypox. The last date for submission of EOI was August 10.

Meanwhile, the national capital on Saturday reported one more monkeypox infection, taking the case tally to 5. Of the five infected patients, one has been discharged and four are being treated at LNJP Hospital.

So far, India has reported 10 cases of monkeypox infection.

--IANS

avr/pgh

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :ICMRVaccinehealth care

First Published: Aug 14 2022 | 6:49 AM IST

Next Story